The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours ...

The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...

Chinese clinical scientist Wang Yongjun has been granted the William M Feinberg Award for Excellence in Clinical Stroke at the 2025 International Str ...

In a randomized clinical trial in China, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms ...

Mechanically retrieving a blood clot blocking a medium- or small-sized brain artery was no better at reducing disability 90 ...

A protocol designed to progressively increase physical therapy intensity for stroke survivors improved walking distance, ...

"The findings of the PUMICE randomized clinical trial indicate that thrombolysis with prourokinase did not demonstrate ...

Researchers have found in a new research that among patients with atrial fibrillation who are at moderate-to-high risk for ...

Eleven scientists will be recognized for their individual exceptional professional achievements and contributions to stroke care and research during the American Stroke Association’s International ...